Trial Condition(s):

Medicated Intrauterine Devices, Contraception

Mirena efficiency and tolerability during the first year of use

Bayer Identifier:

91295

ClinicalTrials.gov Identifier:

NCT00696202

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In this trial the efficacy and safety of Mirena was investigated during the first year of use

Inclusion Criteria
- Women aged 25 to 39 years who sought effective contraception during the post-partum period (i.e. insertion of the device between 6 and 12 weeks after parturition).
Exclusion Criteria
- Standard exclusion criteria for use of intrauterine hormone devices

Trial Summary

Enrollment Goal
199
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Centre de Gynecologie Obstetrique

Amiens Cedex 01, France, 80054

Status
Completed
 

Trial Design